Clinical immersion programs are fully customizable education and training courses developed in partnership with multidisciplinary teams at centers of excellence or community practices. These programs are consistently ranked as top educational training courses for life science companies. But as COVID-19 continues to spread, in-person events may not be safe or sustainable. Companies still rely on […]

After some of the important 2019 conferences have come to an end, it’s time to reevaluate your product’s or corporate messaging and decide how it fits within the trending insights and newsworthy industry knowledge you gathered from your experiences. Learning about the appropriate evolution of your marketing message post-congress is key to maintaining its buzz—from […]

Mutation testing using cell-free (cf) DNA is becoming increasingly common in oncology, particularly as a tool in tumors that commonly have driver mutations, such as non-small cell lung cancer. Circulating cf tumor DNA in the plasma is now routinely being used alongside traditional tissue-based testing to guide treatment selection and detect resistance mutations upon progression. […]

In today’s fast-paced world, it can be hard to schedule in-person meetings with stakeholders. Yet medical companies face more pressure than ever to connect with stakeholders, or risk missing out on valuable networking opportunities. Virtual collaboration platforms have emerged to help fill this gap. Savvy marketers can now use modern technology to meet stakeholders with […]

When life science companies visualize their ideal key opinion leaders (KOLs) for cancer treatments, they typically think of oncologists and/or hematologists. But in their rush to connect with skilled physicians, many pharmaceutical companies in the United States overlook a vital resource: the rest of the oncology care team. Cancer patients don’t receive care from an […]

According to a population study published recently in JAMA Oncology, cancer survivors are more likely to suffer from chronic pain and high-impact chronic pain than the general population. The study evaluated long-term outcomes among 4526 adult cancer survivors included in the US National Health Interview Survey. Chronic pain occurred in 1648 (34.6%) and high-impact chronic […]